Search Results 1961-1970 of 13637 for monoclonal antibody
The purpose of this study is to evaluate the immune and hematopoietic compartments in patients with monoclonal B cell lymphocytosis (MBL) and chronic ...
At risk for HBV reactivation is defined as hepatitis B surface antigen positive or anti-hepatitis B core antibody positive. Previous test results obtained ...
Antibodies: ≥ 21 days must have elapsed from infusion of last dose of antibody, and toxicity related to prior antibody therapy must be recovered to Grade ≤ 1.
... antibody (HBcAb) test; patient must not have active hepatitis C virus (HCV) infection as evidenced by testing performed within 28 days prior to registration ...
Biotinylated antibodies against CD40, CD86, CD11b, CD11c and MHC II. Biotinylated protein ligands targeting toll-like receptors and scavenger receptors ...
... antibody, or Hepatitis C (HCV). For HCV, a positive HCV antibody test is exclusionary unless the recipient is known to have been treated for HCV, in which ...
The purpose of this study is to determine the cellular and mechanistic basis of bone marrow hematopoietic dysfunction in untreated Monoclonal B Cell ...
Serum monoclonal protein ≥ 1.0 g/dL; ≥ 200 mg of monoclonal protein in the urine on 24 hour electrophoresis; Serum immunoglobulin free light chain (involved ...
... antibodies against microorganisms, and inflammatory markers (e.g., leukocyte esterase, CRP) in synovial fluid for the diagnosis of prosthetic joint ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.